MeiraGTx Holdings plc to Participate in Evercore HealthCONx Conference
MeiraGTx Holdings plc will participate in the 8th Annual Evercore HealthCONx Conference on December 2, 2025, presenting data on selective ROCK2 inhibitors for obesity from Graviton Bioscience. The presentation will focus on preclinical efficacy, target biology, and potential for sustained fat loss with muscle preservation. This news was generated by Public Technologies using AI and is for informational purposes only.
MeiraGTx Holdings plc will attend the 8th Annual Evercore HealthCONx Conference on December 2, 2025. The company will present data from Graviton Bioscience on selective ROCK2 inhibitors for obesity, highlighting preclinical efficacy, target biology, and the potential for sustained fat loss with muscle preservation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via PR Newswire (Ref. ID: NY30369) on November 20, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
